Abstract
Heparan sulfate (HS) with various sulfation patterns is one of important modulators of cancer cell fate through interacting with numerous growth factors. Here we found HS 2-O sulfotransferase 1 (HS2ST1) was downregulated at both mRNA and protein levels during granulocytic differentiation of SKM-1 leukemia cells and also HS (glucosamine) 3-O sulfotransferase 3A (HS3ST3A) in epithelial-mesenchymal transition (EMT) of A549 lung cancer cells, meanwhile, cell-surface HS recognized by anti-HS antibody was also changed in both cancer cell lines. Further, HS3ST3A was negatively correlated with the in vitro cell metastasis capability of A549 cells confirmed by RNA interference technology, wound-healing assay and in vitro Matrigel invasion assay. Together, specific HS sulfotransferases may serve as molecular markers and targets for cancer treatment.
Similar content being viewed by others
References
Knelson, E.H., Nee, J.C., Blobe, G.C.: Heparan sulfate signaling in cancer. Trends Biochem. Sci. 39, 277–288 (2014)
Raman, R., Sasisekharan, R.: Cooperativity in glycan-protein interactions. Chem. Biol. 14, 873–874 (2007)
Habuchi, H., Habuchi, O., Kimata, K.: Sulfation pattern in glycosaminoglycan: does it have a code? Glycoconj. J. 21, 47–52 (2004)
Nurcombe, V., Ford, M.D., Wildschut, J.A., Bartlett, P.F.: Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science. 260, 103–106 (1993)
Dhoot, G.K., Gustafsson, M.K., Ai, X., Sun, W., Standiford, D.M., Emerson Jr., C.P.: Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science. 293, 1663–1666 (2001)
Vlodavsky, I., Ilan, N., Naggi, A., Casu, B.: Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr. Pharm. Des. 13, 2057–2073 (2007)
Lemjabbar-Alaoui, H., van Zante, A., Singer, M.S., Xue, Q., Wang, Y.-Q., Tsay, D., He, B., Jablons, D.M., Rosen, S.D.: Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis. Oncogene. 29, 635–646 (2010)
Zhao, S., Deng, C., Wang, Z., Teng, L., Chen, J.: Heparan sulfate 6-O-sulfotransferase 3 is involved in bone marrow mesenchymal stromal cell osteogenic differentiation. Biochemistry (Mosc). 80(379–89), (2015)
Ferguson, B.W., Datta, S.: Role of heparan sulfate 2-o-sulfotransferase in prostate cancer cell proliferation, invasion, and growth factor signaling. Prostate cancer. 2011(893208), (2011)
Backen, A.C., Cole, C.L., Lau, S.C., Clamp, A.R., McVey, R., Gallagher, J.T., Jayson, G.C.: Heparan sulphate synthetic and editing enzymes in ovarian cancer. Br. J. Cancer. 96, 1544–1548 (2007)
Kai, S., Qin, L., Yong-Bo, P., Jie, L., Kan, D., Li-Juan, C., Cheng-Hao, S., Li-Jun, Z., Ping, L.: Silencing of hHS6ST2 inhibits progression of pancreatic cancer through inhibition of notch signalling. Biochem. J. 436, 271–282 (2011)
Tátrai, P., Egedi, K., Somorácz, Á., Van Kuppevelt, T.H., Ten Dam, G., Lyon, M., Deakin, J.A., Kiss, A., Schaff, Z., Kovalszky, I.: Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer. J. Histochem. Cytochem. 58, 429–441 (2010)
Miyamoto, K., Asada, K., Fukutomi, T., Okochi, E., Yagi, Y., Hasegawa, T., Asahara, T., Sugimura, T., Ushijima, T.: Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Oncogene. 22, 274–280 (2003)
Pirozzi, G., Tirino, V., Camerlingo, R., Franco, R., La Rocca, A., Liguori, E., Martucci, N., Paino, F., Normanno, N., Rocco, G.: Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line. PLoS One. 6, e21548 (2011)
Soltermann, A., Tischler, V., Arbogast, S., Braun, J., Probst-Hensch, N., Weder, W., Moch, H., Kristiansen, G.: Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non–small cell lung cancer. Clin. Cancer Res. 14, 7430–7437 (2008)
Smith, R.A., Meade, K., Pickford, C.E., Holley, R.J., Merry, C.L.: Glycosaminoglycans as regulators of stem cell differentiation. Differentiation. 5, 7 (2011)
Stasi, R., Brunetti, M., Terzoli, E., Amadori, S.: Sustained response to recombinant human erythropoietin and intermittent all-trans retinoic acid in patients with myelodysplastic syndromes. Blood. 99, 1578–1584 (2002)
Rollison, D.E., Howlader, N., Smith, M.T., Strom, S.S., Merritt, W.D., Ries, L.A., Edwards, B.K., List, A.F.: Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood. 112, 45–52 (2008)
Wen, C., Dehnel, T.: China wrestles with lung cancer. Lancet Oncol. 12, 15 (2011)
Bui, C., Ouzzine, M., Talhaoui, I., Sharp, S., Prydz, K., Coughtrie, M.W., Fournel-Gigleux, S.: Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells. FASEB J. 24, 436–450 (2010)
Bishop, J.R., Schuksz, M., Esko, J.D.: Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature. 446, 1030–1037 (2007)
Blackhall, F.H., Merry, C.L., Davies, E., Jayson, G.C.: Heparan sulfate proteoglycans and cancer. Br. J. Cancer. 85, 1094 (2001)
Fujiyoshi, M., Kuno, A., Gotoh, M., Fukai, M., Yokoo, H., Kamachi, H., Kamiyama, T., Korenaga, M., Mizokami, M., Narimatsu, H.: Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma. J Gastroenterol. 1–11 (2015)
Kuberan, B., Beeler, D.L., Lech, M., Wu, Z.L., Rosenberg, R.D.: Chemoenzymatic synthesis of classical and non-classical anticoagulant heparan sulfate polysaccharides. J. Biol. Chem. 278, 52613–52621 (2003)
Lawrence, R., Yabe, T., HajMohammadi, S., Rhodes, J., McNeely, M., Liu, J., Lamperti, E.D., Toselli, P.A., Lech, M., Spear, P.G.: The principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissues. Matrix Biol. 26, 442–455 (2007)
Xia, G., Chen, J., Tiwari, V., Ju, W., Li, J.-P., Malmström, A., Shukla, D., Liu, J.: Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J. Biol. Chem. 277, 37912–37919 (2002)
Bernfield, M., Götte, M., Park, P.W., Reizes, O., Fitzgerald, M.L., Lincecum, J., Zako, M.: Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729–777 (1999)
Guo, Y., Li, Z., Lin, X.: Hs3st-a and Hs3st-B regulate intestinal homeostasis in Drosophila adult midgut. Cell. Signal. 26, 2317–2325 (2014)
Thacker BE, Xu D, Lawrence R, Esko JD: Heparan sulfate 3-O-sulfation: a rare modification in search of a function. Matrix Biol. 35, 60–72 (2014)
Thiery, J.P., Acloque, H., Huang, R.Y., Nieto, M.A.: Epithelial-mesenchymal transitions in development and disease. Cell. 139, 871–890 (2009)
Yue, X., Li, X., Nguyen, H.T., Chin, D.R., Sullivan, D.E., Lasky, J.A.: Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo. J. Biol. Chem. 283, 20397–20407 (2008)
Ferreras, L., Moles, A., Situmorang, G.R., El Masri, R., Wilson, I.L., Cooke, K., Thompson, E., Kusche-Gullberg, M., Vives, R.R., Sheerin, N.S., Ali, S.: Heparan sulfate in chronic kidney diseases: exploring the role of 3-O-sulfation. Biochim. Biophys. Acta Gen. Subj. 1863, 839–848 (2019)
Hwang, J.-A., Kim, Y., Hong, S.-H., Lee, J., Cho, Y.G., Han, J.-Y., Kim, Y.-H., Han, J., Shim, Y.M., Lee, Y.-S.: Epigenetic inactivation of heparan sulfate (glucosamine) 3-o-sulfotransferase 2 in lung cancer and its role in tumorigenesis. PLoS One. 8, e79634 (2013)
Mochizuki, H., Yoshida, K., Shibata, Y., Kimata, K.: Tetrasulfated disaccharide unit in heparan sulfate enzymatic formation and tissue distribution. J. Biol. Chem. 283, 31237–31245 (2008)
Denys, A., Allain, F.: The emerging roles of Heparan sulfate 3-O-Sulfotransferases in Cancer. Front. Oncol. 9, 507 (2019)
Nagarajan, A., Malvi, P., Wajapeyee, N.: Heparan sulfate and Heparan sulfate proteoglycans in Cancer initiation and progression. Front Endocrinol (Lausanne). 9(483), (2018)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Author disclosure statement
No competing financial interests exist.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhao, S., Wang, Z. Changes in heparan sulfate sulfotransferases and cell-surface heparan sulfate during SKM-1 cells granulocytic differentiation and A549 cells epithelial-mesenchymal transition. Glycoconj J 37, 151–164 (2020). https://doi.org/10.1007/s10719-019-09903-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-019-09903-0